Synbio International, Inc. SYIN
Set alert
0.00 USD 0.00 -25.00%
As of Nov 2, 1:21 PM ET
0.0003 Day range 0.0003
0.0002 52-week range 0.004
- YTD
- -87.50%
- 1 year
- -88.46%
- Open
- 0.0003
- Prev close
- 0.0004
- Mkt cap
- 122.68K
- Vol
- 500.00K
- Avg vol
- 5.53M
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0003
- High
- 0.0003
2Y chart
Signals (86)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 19, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 14, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 21, 2026 | 3 months ago |
| RSI: Oversold | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 22, 2026 | 5 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| RSI: Oversold | Mar 24, 2026 | 7 months ago |
| RSI: Oversold | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 12, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 11, 2026 | 7 months ago |
| RSI: Oversold | Feb 25, 2026 | 8 months ago |
Newest 20 of 86.
News
- Synbio (OTC: SYIN) Outlines a Two-Engine Healthcare Growth Strategy Combining Nutraceuticals and AI-Powered Mental Health Screening
- Synbio International Signs Exclusive Licensing Agreement for Proprietary Nutraceutical Products, Accelerating Path to Revenue
- Synbio International Commences Revenue-Generating Operations With Launch of Healing Force™ Nutraceutical Division
- Synbio International Secures DWAC and DRS Eligibility
- Synbio Signs Agreement for a Proof-of-Concept Clinical Trial to Evaluate a Unique AI-Based Facial Analysis Screening Software for Mental Health Disorders
- Synbio International Inc. Expands its Board of Directors and Strengthens its Clinical Leadership with the Appointment of Dr. Nick Vatakis
- Synbio International Inc. Expands its Board of Directors and Strengthens its Clinical Leadership with the Appointment of Dr. Nick Vatakis
- Synbio International Inc. Strengthens Strategic Alliance with FacialDx Inc. through Share Purchase and Warrant Agreements
- NATURAL HARMONY FOODS INC. COMPLETES FINANCIAL AUDITS FOR 2022 & 2023
- Natural Harmony Foods Inc. Completes Financial Audits for 2022 & 2023
Your note
Sign in to keep a note on SYIN — it syncs with the Stock Master app.